BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma

Pei Ling Chen, Nastaran Neishaboori, Michael T. Tetzlaff, Wei Shen Chen, Phyu P. Aung, Jonathan L. Curry, Priyadharsini Nagarajan, Doina Ivan, Wen Jen Hwu, Victor G. Prieto, Carlos A. Torres-Cabala

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The family of blue nevi includes the common blue nevus (BN), cellular blue nevus (CBN), and atypical BN, while melanomas with BN-like morphology can either arise in association with a blue nevus (MABN) or in the de novo setting mimicking cellular blue nevus (MMCBN). Recent molecular and immunohistochemical studies have demonstrated loss of BAP-1 in MABN/MMCBN but not in BN/CBN, suggesting that loss of BAP-1 correlates with a malignant phenotype in these lesions. In this study, we applied anti-BAP-1 antibodies to a series of CBN/BN (n = 11) and MABN/MMCBN (n = 4). Nuclear BAP-1 expression was detected in the majority of CBN/BN (n = 10/11) but was lost in 1 case. Most cases of MABN/MMCBN showed loss of nuclear BAP-1 expression (n = 3/4), with one case of MMCBN showing preserved BAP-1 expression. Demonstration of BAP-1 loss in a single case of CBN and preservation of BAP-1 expression in 1 case of MMCBN may indicate that detection of alterations in BAP-1 protein expression by immunohistochemistry may not be a completely reliable biomarker for the distinction of BN/CBN from MABN/MMCBN. Further investigation of the significance of BAP-1 loss/preservation in BN-like tumors is warranted.

Original languageEnglish (US)
Pages (from-to)313-321
Number of pages9
JournalAmerican Journal of Dermatopathology
Volume42
Issue number5
DOIs
StatePublished - May 1 2020

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Fingerprint

Dive into the research topics of 'BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma'. Together they form a unique fingerprint.

Cite this